Leukemia & lymphoma/Leukemia and lymphoma

Leukemia & lymphoma/Leukemia and lymphoma is a subscription journal published by Taylor & Francis in Switzerland. OpenAlex counts 14,278 works from it, cited 254,633 times; its h-index is 125. Its two-year mean citedness, which is computed the way the impact factor is, is 1.82: a paper it published in the two years before was cited about 1.82 times last year. It published 350 papers in 2025, about as many as in 2024.

Publisher
Taylor & Francis
Citations per paper
1.82 two-year mean, OpenAlex
h-index
125 i10-index 7,291
Access
Subscription
ISSN
1026-8022, 1029-2403, 1042-8194
Country
Switzerland
Works published
14,278 cited 254,633 times
Papers in 2025
350
Field
Medicine
Website
Journal home ↗

Leukemia & lymphoma/Leukemia and lymphoma year by year

Papers it published each year, and the citations all its papers received that year.

YearPapers publishedCitations received
2026 so far2829,039
202535011,328
202433412,354
202328513,184
202241413,097
202146514,569
202054313,323
201950111,639

What Leukemia & lymphoma/Leukemia and lymphoma publishes

Its most frequent research topics, by OpenAlex's topic classification.

Questions about Leukemia & lymphoma/Leukemia and lymphoma

What is the impact factor of Leukemia & lymphoma/Leukemia and lymphoma?

Clarivate's Journal Impact Factor is licensed and not shown here. OpenAlex's two-year mean citedness, computed the same way from open data, is 1.82 for Leukemia & lymphoma/Leukemia and lymphoma: on average, each paper it published in the two years before was cited about 1.82 times in a year.

What is the h-index of Leukemia & lymphoma/Leukemia and lymphoma?

125, by OpenAlex's count: 125 of its papers have each been cited at least 125 times. Its i10-index is 7,291.

Is Leukemia & lymphoma/Leukemia and lymphoma open access?

Not fully. Leukemia & lymphoma/Leukemia and lymphoma is a subscription journal; a paper is free to read when its authors paid for open access or posted a copy in a repository.

What is the ISSN of Leukemia & lymphoma/Leukemia and lymphoma?

Its linking ISSN is 1026-8022; all its ISSNs: 1026-8022, 1029-2403, 1042-8194.

Who publishes Leukemia & lymphoma/Leukemia and lymphoma?

Taylor & Francis, based in Switzerland.

How many papers does Leukemia & lymphoma/Leukemia and lymphoma publish a year?

350 in 2025, by OpenAlex's count of what it published that year.

What does Leukemia & lymphoma/Leukemia and lymphoma publish?

Its most frequent research topics are Lymphoma Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research, Acute Myeloid Leukemia Research, in the field of Medicine.

Is Leukemia & lymphoma/Leukemia and lymphoma a predatory journal?

Nothing in the scholarly indexes suggests so. Leukemia & lymphoma/Leukemia and lymphoma is on OpenAlex's list of core sources, journals with peer review and an editorial board, it has published 14,278 works cited 254,633 times. For a journal you do not know, check the red flags with our predatory journal checker.

Is Leukemia & lymphoma/Leukemia and lymphoma indexed in Scopus or Web of Science?

Check the Scopus Sources list and Clarivate's Master Journal List by its ISSN (1026-8022): both are free to search. Our guide on checking journal indexing shows each step.

Journals like Leukemia & lymphoma/Leukemia and lymphoma

Other Medicine journals with a similar impact.

Every Medicine journal, ranked · The journal directory

Journal data from OpenAlex (CC0), compiled 21 November 2026. Download the whole directory as a CSV file (CC BY 4.0).